Toxicology
- General Side Effects
- Alpha-1 Antagonism (Norepinephrine)
- Significant orthostatic hypotension/tachycardia
- MC: Risperidone/Paliperidone, Clozapine, Thioridazine, Trazodone
- Dopamine receptor antagonist
- Metoclopramide
- For nausea and vomiting, may have EPS
- Histamine Antagonism (Histamine)
- Sedation, appetite stimulation, weight gain
- MC: Quetiapine (most sedating), Olanzapine (weight), Clozapine (weight), Thioridazine
- Muscarinic Antagonism (Acetylcholine)
- Anticholinergic – Delirium, fever, tachycardia, flushing, dry mucus membranes, constipation, Confusion and hallucinations
- MC: Olanzapine, Clozapine, Thioridazine, Chlorpromazine
- Side Effect Monitoring
- EKG
- Amitriptyline/TCAs
- CBC
- Clozapine (Agranulocytosis) weekly but not carbamazepine
- Plasma levels
- Lithium, valproate
- Falls
- TCAs and Benzos
- Glucose
- Clozapine after 6 months
- Dextromethorphan (cough syrup)
- Dissociative symptoms and hallucinations
- Add Quetiapine to treat Pseudobulbar Affect
Antipsychotic Extrapyramidal Effects – "ADAPT" | Pharmacotherapy |
---|---|
Acute Dystonia** (4 hours)** | |
- Sudden, sustained contraction of neck, mouth, tongue and eye muscles | |
- Benztropine | |
- Diphenhydramine | |
Akathisia** (Days to weeks)** | |
- Subjective inner restlessness, inability to sit still, wanting to walk off | |
- Dose dependent | |
- Benzodiazepine (Lorazepam) | |
- Low-Dose BB (Propranolol) | |
- Benztropine | |
Parkinsonism** (Weeks to months)** | |
- Gradual-onset tremor, rigidity and bradykinesia | |
- Benztropine≥ | |
- Amantadine | |
- Trihexyphenidyl | |
Tardive dyskinesia** (4 months)** | |
- Gradual onset after prolonged therapy (≥6m): dyskinesia of mouth, face, trunk, extremities | |
- Valbenazine | |
- Deutetrabenazine | |
- Switch to Clozapine or Quetiapine | |
- Acetaminophen Overdose
- Gastroenteritis (non-specific) within hours, hepatoxicity within 1-2 days
- Leading cause of hepatic failure in US
- Treatment
- Activated Charcoal and N-Acetylcysteine
- Liver Transplant
- Alcohol Intoxication
- Slurred speech, incoordination, unsteady gait, attention/memory impairment, stupor, nystagmus
- Alcohol/Methanol Overdose
- Anion Gap Metabolic Acidosis
- Fomepizole
- Inhibits alcohol dehydrogenase
- Alcohol Ketoacidosis
- Slurred speech, unsteady gait, altered mentation
- High Osmolar gap
- Increased anion gap
- Metabolic acidosis due to ketosis
- Alcohol Withdrawal
- Symptoms
- Tachycardia, diaphoresis, anxiety, hallucinations, Seizures
- Macrocytic anemia
- Mild (6-24h) – anxiety, insomnia, tremors, diaphoresis, palpitations, GI upset, intact orientation
- Seizures (12-48h) – single or multiple generalized tonic, clonic
- Alcoholic hallucinosis (12-24h) – visual, auditory, or tactile; intact orientation
- Delirium Tremens (48-96h) – unstable vitals, hallucinations, confusion
- Withdrawal Prophylaxis
- Chlordiazepoxide, Diazepam (medium-acting)
- Treatment
- IV Lorazepam ≥ Chlordiazepoxide
- Especially in Liver disease
- IVF, Thiamine, Folate
- Thiamine prior to glucose
- Anticholinergic Poisoning
- Treatment
- Physostigmine (cholinesterase inhibitors)
- Arsenic Poisoning
- Mechanism
- Binds to sulfhydryl groups
- Disrupts cellular respiration and gluconeogenesis
- Sources
- Pesticides, insecticides
- Contaminated water, often from wells
- Pressure-treated wood
- Miners, smelters
- Clinical
- Acute: Garlic breath, vomiting, watery diarrhea, QTc prolongation
- Dehydration secondary to vomiting and diarrhea
- Seizure, delirium, coma, torsades de pointes
- Acute tubular necrosis
- Painful paresthesia, ascending weakness
- Chronic: Pigmentation, hyperkeratosis, stocking-glove neuropathy
- Cancer: Skin, bladder, kidney, and/or lung
- Mees Lines (Leukonychia striata) on the nails (hypo/hyperpigmented)
- Diagnosis: Elevated urine Arsenic Levels
- Treatment
- IM Dimercaprol (British anti-Lewisite)
- DMSA (meso-2,3-dimercaptosuccinic acid, Succimer)
- Barbiturate Overdose
- Phenobarbital
- Weak Acids
- Treatment
- Secure airway
- Enhance elimination with Sodium Bicarbonate
- Alkalinization of the urine
- Benzodiazepine Overdose
- Only Benzos = CNS depression with normal vitals
- Altered LOC, ataxia, slurred speech
- Benzos + Alcohol = CNS depression with abnormal vitals
- Alcohol will cause bradycardia, hypotension, respiratory depression, hyporeflexia
- Treatment
- RR Normal (12-20)
- Supportive Treatment
- Emesis, Lavage, Charcoal
- 1 Time Acute Overdose
- Flumazenil
- Avoid Flumazenil if chronic benzo user
- Partial agonist, may precipitate withdrawal/seizures
- Fixes CNS depression, less effective for respiratory
- SE: Re-sedation, hypotension, hypertension, seizures in long term users, arrhythmias, angina
- Beta Blocker Overdose
- Bradycardia, AV block, and diffuse wheezing in a CAD patient
- Drowsiness, fatigue, depression, Bradycardia, Torsade de points, worsening HF, hypertriglyceridemia, bronchoconstriction, ED, Weight gain
- Treatment
- Hypotension: IV Glucagon
- Atropine, IV fluids
- Carbon Monoxide Poisoning
- Treatment
- 100% O2
- Hyperbaric Oxygen if CO is ≥25-40%
- Lower if pregnant
- Cocaine Toxicity
- Inhibits norepinephrine reuptake into the sympathetic neuron (potentiating sympathomimetic actions)
- Alpha and beta receptor stimulation results in coronary vasoconstriction and increased HR, Systemic BP, and Myocardial O2 demand
- Enhances thrombus formation by promoting platelet activation and aggregation
- Age \<30 w/o FH, severe or malignant hypertension, resistant hypertension, sudden rise in BP
- Sympathetic hyperactivity
- Symptoms
- Personality/mood changes, sleep loss, weight loss, financial difficulties
- Chest pain, epistaxis, rhinitis, headaches
- Cocaine-related Chest Pain (CRCP)
- Can occur due to non-cardiac causes (hemorrhagic alveolitis, pneumothorax)
- Hypertension, tachycardia, dilated pupils, psychomotor agitation, tremors
- Complications
- Seizures, Acute MI, Aortic Dissection, Intracranial hemorrhage
- Diagnosis: Urine Drug Screen
- Treatment of NSTEMI/Chest Pain:
- Benzodiazepines for BP and Anxiety and O2 (lorazepam, diazepam)
- Reduce sympathetic outflow (alleviate tachycardia, hypertension)
- ± Phentolamine if above doesn't work
- Aspirin
- Nitroglycerin and CCBs for pain
- Beta blockers are contraindicated
- Would worsen coronary vasoconstriction (unopposed alpha-adrenergic stimulation)
- No fibrinolytics
- ± Immediate Cardiac Catheterization
- Cyanide Accumulation and Cyanide Toxicity
- Cyanide is a potent inhibitor of cytochrome oxidase-a3 in the mitochondrial ETC
- Inhibits cellular respiration
-
RF: Smoke inhalation (Mc toxicity in house fires)
- Up to 90% of pts in house fires, only 35% have CO poisoning
- Sodium Nitroprusside for hypertensive emergency
- Prolonged use can lead to toxicity
- More common in patients with renal insufficiency, signs of CHF
- Onset is ~14-24 hours
- Symptoms
- Skin: Flushing before cyanosis
- CNS: HA, AMS, seizures, coma, confusion, agitation
- CV: Arrhythmias
- Resp: Tachypnea followed by respiratory depression, Pulmonary edema
- BP instability
- GI: Pain, nausea, vomiting
- "Almond like" odor to the breath
- Renal: Metabolic acidosis (lactic acidosis), Renal failure
- Bright red venous blood (elevated ventral venous oxyhemoglobin saturation
- Treatment
- Decontamination
- Dermal
- Remove clothing
- Ingestion
- Activated charcoal
- Antidotes
- 1) Hydroxocobalamin
- Removes cyanide from mitochondrial respiratory system
- 2) Sodium Thiosulphate
- Slower onset, can't be given with #1 or through the same catheter
- 3) Sodium Nitrite
- Only if ingested
- Can't be used in house fire victims due to synergistic effect with CO
- Respiratory
- No mouth-to-mouth resuscitation
- Use supplemental O2/intubation
- Digitalis Toxicity
- Blocks na/k ATPase in myocardial cells
- Leading to influx of calcium, increased contractility, increased SV
- Prolongs refractory period reducing ventricular rate
- Features
- Characteristic ST depression with concave-up morphology "hockey stick"
- AKI w/hyperkalemia and increased creatinine
- Pain, nausea, vomiting
- Confusion
- Yellow halos around light, scotomas, blindness
- Ethylene Glycol Ingestion
- Symptoms
- Flank Pain, hematuria, oliguria, cranial nerve palsies, tetany
- Labs
- High Osmolar gap
- Increased anion gap
- Metabolic acidosis
- Calcium oxalate crystals in the urine
- Treatment
- Fomepizole or Ethanol
- Heparin
- Treatment
- Protamine
- Isopropyl Alcohol Ingestion
- CNS depression, deconjugate gaze, absent ciliary reflex
- High Osmolar gap
- No Increased Anion Gap
- No Metabolic acidosis
- Treatment
- Supportive Care
- Malignant Hypertension (Hypertensive Crisis)
- Binds to RYR1R causing CA2+ release.
- MAOI + tyramine or stimulant
- Prevents breakdown of tyramine in gut
- Enhances peripheral NE effects increasing BP
- Symptoms
- Headache following a meal (tyramine)
- Hypertension, sweating, HA, vomiting
- Sympathomimetic effect (hypertension)
- Labs
- Increased BUN
- Complications: Stroke, intracranial bleeding, death, rhabdomyolysis
- Treatment
- Stop agent
- IV phentolamine
- Dantrolene
- Nifedipine can be helpful
- Thyroxine (T4) is treated with IV thyroxine for myxedema
- Coma required more
- Methanol Ingestion
- Visual Blurring, central scotomata, afferent pupillary defect, altered mentation, epigastric pain, hyperemic optic disc
- High Osmolar gap
- Increased anion gap
- Metabolic acidosis
- Treatment
- Fomepizole (inhibits the alcohol dehydrogenase that converts methanol to formaldehyde)
- Ethanol
- Methemoglobinemia
- Formed by the oxidation of ferrous to ferric iron in hemoglobin
- Left shirt in the O2 curve because ferric iron cannot bind oxygen and this o2 binds tighter to ferrous iron in hemoglobin
- Functional anemia
- Causes: Dapsone, nitrates, topical/local anesthetics
- Treatment
- Methylene Blue
- Neuroleptic Malignant Syndrome (NMS)
- Antagonism of Dopamine (D2) receptors in the nigrostriatal pathway
- Can occur with every class of antipsychotics
- Symptoms
- Slow onset, clouding of consciousness (over 1-3 days w/delirium being the 1st symptom)
- Fever ≥104F, confusion, delirium or catatonia
- Muscle rigidity (Lead-pipe), General muscle rigidity
- Autonomic instability (Tachypnea, hypertension, tachycardia, dysrhythmia)
- Abnormal vitals, sweating, mydriasis
- Labs
- Increased CPK, LFTs, WBCs
- Myoglobin in urine
- Treatment
- Stop antipsychotics or restart dopamine agents
- Antipsychotic meds
- May have increases Creatine Kinase and WBCs
- IV fluids, supportive care; ICU
- Benzodiazepines
- Dantrolene (skeletal muscle relaxant) or bromocriptine (dopamine agonist), amantadine (dopamine agonist) if refractory
- Opioids
- Treatment
- Buprenorphine
- Partial mu agonist, kappa antagonist
- Treats withdrawal and chronic pain
- Combined with naloxone (blocks receptor)
- Naltrexone
- Treats dependence, not withdrawal
- Methadone
- Treats withdrawl
- Organophosphate Toxicity
- Excessive salivation, miosis, lacrimation, diarrhea, emesis, urination, bronchospasm
- Bradycardia, heart block, prolonged QTc
- Treatment
- Pralidoxime
- Reverses muscle paralysis (nicotinic effects)
- Atropine
- Phencyclidine (PCP) Overdose
- NMDA and Ach Antagonism
- Particularly in the hippocampus and limbic system
- Dopamine, norepinephrine, and serotonin receptor activation
- Sigma receptor complex activation causing psychotic and anticholinergic effects
- Lasts \<8 hours
- PCP withdrawal
- Depression
- Ketamine is shorter acting
- Vertical or horizontal nystagmus, ataxia, violent behavior, hyperthermia, disorientation, delusions, muscle rigidity
- Treatment
- Psychomotor Agitation: Parenteral Benzodiazepines (lorazepam, diazepam) ≥ Haloperidol unless seizure disorder is present
- B52 – Haloperidol, diphenhydramine, and benzodiazepine
- Phenytoin Toxicity
- Vertical Nystagmus
- Cerebellar-vestibular system affected
- Sedation, hypotension, arrhythmias, GI disturbances
- Gingival hyperplasia and hirsutism if long-term use
- 2nd line anticonvulsant (after lorazepam) in treating status epilepticus
- Decreases repetitive firing of neuronal action potentials by slowing the rate of recovery of voltage gated sodium channels from inactivation
- SE: SJS
- Salicylate Poisoning
- Treatment
- Gastric Lavage, Activated charcoal, alkalinization of the urine, diuresis, dialysis
- Serotonin Discontinuation Syndrome
- RF: SSRIs with short half-life and no active metabolites
- MC with short half-life SSRIs (paroxetine ≥ venlafaxine)
- Onset within 3 days of discontinuation, resolution within 1-2 weeks
- Fatigue, insomnia, myalgias from abrupt discontinuation in 20%
- Headaches, anxiety, agitation
- "Weird" sensations along arms and legs, "electric-shock-like" sensations in head/neck, "rushing" sensations in the head
- Vertigo, tremor, ataxia
- Treatment
- Restart drug and taper gradually over several weeks (6-8 weeks)
- If persistent, switch to Fluoxetine
- Serotonin Syndrome (SS)
- General
- Over stimulation of 5-HT receptors in the central grey nuclei and the medulla
- MC with stopping sertraline and fluvoxamine
- Fluoxetine has a long half-life, must be quit 5 weeks prior to MAOI, but doesn't need to be tapered
- Tramadol (Ultram)
- Serotonergic analgesic + SSRIs
- Symptoms
- Activity (hyperactivity, hyperreflexia, hypertonia, tremor, seizure)
- Myoclonus, Lower extremity rigidity, tremor
- Autonomic (hyperthermia, diaphoresis, diarrhea, mydriasis)
- Flushing, Tachycardia, hypertension
- Agitation (Need AMS)
- Anxiety, confusion, hypomania, coma
- Headaches, N/V/D, dizziness and fatigue when suddenly stopping
- Exam
- Hyperreflexia and myoclonus
- Diaphoresis, hypertension, tachycardia
- Fever/Hyperthermia, cardiovascular collapse
- Labs
- No CPK or liver enzyme changes
- Treatment
- Discontinue serotonergic meds, supportive, benzodiazepines, cyproheptadine
- Cyclobenzaprine
- Cyproheptadine (H1 receptor antagonist)
- Weakly cholinergic hypotension
- Steroids
- Glucocorticoids/Prednisone (Asthma/Lupus)
- Delusions/hallucinations. Alert and cognitively intact
- Anxiety, depression, psychosis, mania rarely
- Usually occur during the first week but may occur at any time
- Tardive Dyskinesia
- 98% get worse with acute cessation of antipsychotic
- D2 receptor upregulation and super sensitivity
- Chronic blockade of dopamine receptors causes this
- Treatment
- Switch from risperidone to clozapine (atypical antipsychotic)
- VMAT2 Inhibitors
- Blocks presynaptic dopamine release
- May cause depletion of dopamine in synaptic cleft causing depression
- Deutetrabenazine (Austedo)
- TD and Huntington's
- Valbenazine (Ingrezza)
- Reserpine
- TCA (Tricarboxylic Acid) Overdose
- Features
- Antihistamine Effects
- Drowsiness, delirium, coma, seizures, respiratory depression
- Anticholinergic Effects
- Dry mouth, blurred vision, mydriasis, urinary retention
- Flushing, hyperthermia
- Hypotension, sinus tachycardia, prolonged PR/QRS/QT, Arrythmias
- QRS ≥ 100ms is MC EKG abnormality
- 1500mg for ≥4 hours = death
- Treatment
- O2 and intubation, EKG monitoring
- IV fluids
- Activated charcoal if within 2 hours of ingestion (unless ileus present)
- Seizures: Benzodiazepines
- QRS ≥100: IV Sodium Bicarbonate
- Therapy for QRS widening or ventricular arrythmia
- QRS ≥ 100msec is associated with increased risk of arrhythmias and/or seizures
- Cardioprotective and helps metabolic acidosis
- Theophylline Toxicity
- Toxic form reduced clearance or decreased metabolism in the liver
- CNS Stimulation (headache, insomnia, seizures), GI (Nausea, vomiting), and cardiac toxicity (arrhythmia)
- Measure theophylline levels
- tPA
- Treatment
- Aminocaproic Acid
- Warfarin
- Treatment
- Vitamin K, FFP